Clinical trial Recruiting at 1 site Interventional Ages 1 Hour to 3 Days

External negative pressure during lighter-invasive surfactant administration

Official title: AN EXTERNAL NEGATIVE PRESSURE USE DURING THE LISA PROCEDURE. A FEASIBILITY STUDY

Run by Charles University, Czech Republic · NCT07271368 · Data updated 2026-11-12

This study tests whether applying gentle external suction during LISA helps preterm babies breathe better and makes surfactant delivery safer.

Quick facts

Study typeInterventional
Ages1 Hour to 3 Days
SexAll
Enrollment25 (estimated)
SponsorCharles University, Czech Republic
Academic / other
Locations1 site (Prague, Praha 2)
StatusRecruiting
StartedMarch 17, 2025
Main results expectedMarch 30, 2027
Study endsDecember 31, 2027
Registry record updatedAugust 21, 2026
Trial IDNCT07271368 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Preterm infants ≥32 weeks gestation with RDS on CPAP or HFNC, requiring FiO2 >0.30 or showing increased work of breathing, and birth weight >800 g.

Probably not a fit

Infants requiring endotracheal intubation before surfactant or those with major congenital anomalies or neuromuscular/metabolic disorders may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study examines the safety and potential effectiveness of using external continuous negative pressure (ECNP) during less invasive surfactant administration (LISA) in preterm infants with respiratory distress syndrome who are supported by non-invasive ventilation. ECNP is applied via a soft cuirass to promote more uniform lung inflation and potentially improve surfactant distribution. The study is single-arm and focuses on feasibility, safety, and preliminary signals of benefit, including improved oxygenation and fewer procedure-related complications. Outcomes include the rate of desaturation, bradycardia, apnea, and need for repeat surfactant dosing. Eligible infants are monitored closely during the LISA procedure to assess any adverse events and procedural feasibility.

Why it matters

Potential benefit: If successful, ECNP during LISA could improve surfactant delivery and oxygenation, possibly reducing complications and the need for re-dosing.

How similar studies have gone: This approach is novel for LISA; prior methods have not evaluated ECNP during surfactant administration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Preterm infants ≥ 32 weeks of gestational age
* FiO₂ \> 0.30 for more than 30 minutes on CPAP (6 - 8 cm H₂O) or HFNC (8 l/min)
* Increased work of breathing despite FiO₂ \< 0.30
* Birth weight \> 800 g
* X-ray confirmed RDS
* Availability of all required devices and appropriately fitting cuirass

Exclusion Criteria:

* Requirement for endotracheal intubation or mechanical ventilation prior to surfactant administration
* Major congenital anomalies (cardiac, pulmonary, chromosomal)
* Known or suspected neuromuscular or metabolic disorders
* Lack or withdrawal of informed parental consent

Where it's running

  • Klinika gynekologie, porodnictví a neonatologie
    Prague, Praha 2, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.